Clinical Trials in Houston

Showing 3241-3260 of 15,366 trials

Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC

NCT05663710

To learn if giving 177Lu girentuximab in combination with cabozantinib plus nivolumab can help to control advanced clear cell renal cell carcinoma (ccRCC).

Advanced CancerClear Cell Renal Cell Carcinoma

M.D. Anderson Cancer Center100 participantsStarted Jun 2023

Houston, Texas, United States

RECRUITINGPhase 2< 1 mile

A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy

NCT06537999

The purpose of this Phase 2 study is to evaluate the safety, tolerability, pharmacometrics, and efficacy of DNTH103 in participants with multifocal motor neuropathy (MMN).

Multifocal Motor Neuropathy

Dianthus Therapeutics36 participantsStarted Sep 2024

Scottsdale, Arizona, United States • Los Angeles, California, United States • Bradenton, Florida, United States +23 more locations

Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC

A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy

Find Trials by Condition in Houston

A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment

VItamin C in Thermal injuRY: The VICToRY Trial

CBX-12 for the Treatment of Metastatic Chemotherapy-Refractory Microsatellite Stable Colorectal Cancer

MB-105 in Patients With CD5 Positive T-cell Lymphoma

Study of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL)

Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)

Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)

EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction

P-15L Bone Graft in Transforaminal Lumbar Interbody Fusion With Instrumentation

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal Seizures

Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant

Identification of Predictors for Clinical Outcomes in Femoroacetabular Impingement Surgery

A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080)

Expanded Access Protocol for Patients With Eosinophilic Esophagitis

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age

Improving Outcomes Assessment in Chronic GVHD